DNA Link Inc (127120) — Cash Flow-to-Debt Ratio
DNA Link Inc (127120) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of ₩-3.18 Billion could theoretically repay 0% of its total liabilities (₩54.44 Billion) in one year. See free cash flow generation of DNA Link Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DNA Link Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for DNA Link Inc across 14 annual periods. Also explore DNA Link Inc (127120) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for DNA Link Inc (2011–2025)
Year-by-year debt coverage analysis for DNA Link Inc. For market capitalisation and broader financial context, see DNA Link Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.17x | ₩-9.39 Billion | ₩54.44 Billion | ▲ +25.4% |
| 2024 | -0.23x | ₩-6.78 Billion | ₩29.36 Billion | ▲ +42.7% |
| 2023 | -0.40x | ₩-5.03 Billion | ₩12.48 Billion | ▼ -791.4% |
| 2022 | 0.06x | ₩910.27 Million | ₩15.62 Billion | ▲ +107.5% |
| 2021 | -0.78x | ₩-6.43 Billion | ₩8.25 Billion | ▼ -1370.3% |
| 2020 | 0.06x | ₩849.38 Million | ₩13.84 Billion | ▲ +176.7% |
| 2019 | -0.08x | ₩-1.30 Billion | ₩16.24 Billion | ▲ +22.8% |
| 2018 | -0.10x | ₩-1.60 Billion | ₩15.46 Billion | ▲ +94.1% |
| 2017 | -1.77x | ₩-2.49 Billion | ₩1.41 Billion | ▼ -1026.6% |
| 2016 | -0.16x | ₩-3.77 Billion | ₩24.04 Billion | ▲ +9.5% |
| 2015 | -0.17x | ₩-3.73 Billion | ₩21.53 Billion | ▼ -1442.2% |
| 2014 | -0.01x | ₩-143.14 Million | ₩12.74 Billion | ▲ +82.3% |
| 2012 | -0.06x | ₩-783.00 Million | ₩12.33 Billion | ▲ +76.7% |
| 2011 | -0.27x | ₩-2.44 Billion | ₩8.97 Billion | — |